HairMax LaserComb Receives Approval by the Singapore Health Science Authority
Lexington Int’l announces approval by the Singapore Health Science Authority for the HairMax LaserComb as a home-use laser phototherapy medical device for the treatment of hair loss and the promotion of hair growth.
Oct. 24, 2013 - BOCA RATON, Fla. -- Boca Raton, FL - Lexington International, LLC, is the developer and manufacturer of the HairMax LaserComb® laser phototherapy medical device, for the treatment of hereditary hair loss in men and women. The HairMax LaserComb incorporates a patented hair parting teeth mechanism which assures optimal delivery of laser energy to the hair follicles. Further, the HairMax is the only home use laser phototherapy device proven safe and effective in 7 clinical trials with 460 subjects and has US FDA marketing clearance for the treatment of hereditary hair loss.
The Singapore Health Science Authority granted approval to market the three models of the device, the HairMax Advanced 7, HairMax Lux 9, and HairMax Professional 12 for sale directly to consumers and also through doctors’ offices, retail outlets and pharmacies. The hair care market (which includes products for hair loss) in Singapore had total revenue of approximately USD126 million in 2012 according to Datamonitor, and has demonstrated growth of 5.9% a year between 2008 and 2012. This makes Singapore an ideal market opportunity for the HairMax LaserComb.
With this approval, men and women in Singapore now have a new and effective non-drug treatment option to treat their hair loss in the privacy and convenience of their home. The approval was based on results of major clinical studies of men and women suffering from the most common form of hair loss, Androgenetic Alopecia (pattern hair loss). The results of these studies showed a statistically significant increase in average hair growth of subjects on the HairMax LaserComb vs. those on the control device. The studies also demonstrated that 93% of the subjects using the HairMax LaserComb experienced hair regrowth. During the study, no serious side effects occurred.
Desmond Ng, Market Development Director of the distributor of the HairMax in Singapore said: “We, in United Italian Trading Corporation, are privileged to partner with Lexington to introduce HairMax LaserComb to the Singapore market, which offers an evidence-based, non-drug treatment option for many people suffering from male-pattern and female-pattern baldness. We are also proud that it is the only medical device recommended by doctors in the National Skin Centre, National University Hospital and Changi General Hospital, and by many specialists in leading private clinics for treating androgenetic alopecia”. The HairMax can be purchased at the web site, www.hairmax.com or at the local distributor,http://www.uitc.com.sg/
David Michaels, Managing Director of Lexington states; “Southeast Asia is an important market for the HairMax LaserComb as it demonstrating extraordinary growth. Gaining approval in Singapore is another major step forward in our marketing efforts .This approval now enables the HairMax to reach a significantly larger audience of people suffering from hair loss in that part of the world”. Mr. Michaels further stated, “Lexington will continue to pursue additional international medical device registrations to assure further availability of the HairMax LaserComb to the millions of people suffering from hair loss around the world.”
About Lexington International, LLC
Based in Boca Raton, Lexington International is a manufacturer and developer of advanced medical laser devices to treat hair loss and scalp disorders. Lexington International markets the only laser phototherapy device which has published results of clinical trial proving efficacy and safety in a peer review journal. Over the past 8 years and in over 155 countries worldwide, Lexington Int., LLC has helped hundreds of thousands of individuals to treat their hair condition and enrich their lives(www.hairmax.com)